Radiation Oncology/Therapy: Page 19

ITM begins Lu-177 production

By AuntMinnie.com staff writers

ITM Isotope Technologies Munich has launched a new system to expand its production of the therapeutic radioisotope lutetium-177 (Lu-177) in collaboration with partners Bruce Power and Isogen.

October 23, 2022

ASTRO: Radiation to prevent pain may also prolong life

By Matthew Limb

Radiation oncologists could play a key role in treating widespread bone metastases even in the absence of symptoms, according to research presented at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio.

October 23, 2022

ASTRO: Physicists add value in patient-facing role

By Matthew Limb

Radiation therapy patients report less anxiety when a medical physicist explains technical aspects of care and how it is delivered, according to research presented at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio.

October 23, 2022

ASTRO: Shortened radiotherapy is effective in high-risk prostate cancer

By Matthew Limb

Men with high-risk prostate cancer can be treated safely and effectively with just five weeks of radiation therapy, according to research presented at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio.

October 23, 2022

ASTRO: Fresh hopes for ultrahigh-dose radiation treatment

By Matthew Limb

Flash radiation treatment with protons shows promise as a "practical modality to reduce pain," say researchers presenting first-in-human study findings at the American Society for Radiation Oncology (ASTRO) annual meeting in San Antonio.

October 23, 2022

Patients from low-income nations at risk of delayed cancer diagnoses

By Kate Madden Yee

Patients from low-income countries are more vulnerable to delayed cancer diagnoses -- in part due to the fact that it can take 1.5 to 4 times longer than their high-income counterparts for them to seek care, a report published October 20 in PLOS Medicine has found.

October 20, 2022

Philips expands radiation oncology portfolio

By Erik L. Ridley

Philips has unveiled its MR for Calculating Attenuation Head and Neck radiotherapy application and announced the compatibility of its MR Head and Neck Coil with a positioning mask system from MacroMedics.

October 20, 2022

IBA software now compatible with Varian software

By AuntMinnie.com staff writers

Ion Beam Applications (IBA) recently received approval from Varian, a Siemens Healthineers company, to incorporate Varian's Halcyon and Ethos radiotherapy software into its MatriXX Resolution and myQA SRS platforms.

October 19, 2022

Sun Nuclear and Accuray develop new platform

By AuntMinnie.com staff writers

Mirion Technologies subsidiary Sun Nuclear has partnered with Accuray to develop a new quality management platform for Accuray's radiation therapy system.

October 18, 2022

Shine secures Dutch approval for terbium isotope development grant

By AuntMinnie.com staff writers

Shine Technologies has secured approval from the Dutch government for a grant proposal to develop terbium isotopes for nuclear medicine imaging.

October 17, 2022

FDA completes SpectronRx facility inspection

By AuntMinnie.com staff writers

The U.S. Food and Drug Administration (FDA) has completed an inspection of contract development and manufacturing organization SpectronRx's South Bend, Indiana, manufacturing facility.

October 16, 2022

FAPI-PET predicts outcomes in patients with esophageal cancer

By Will Morton

PET imaging with a fibroblast activation protein inhibitor (FAPI) radiotracer may predict whether patients with esophageal cancer will respond to chemoradiotherapy, according to a study published October 13 in the Journal of Nuclear Medicine.

October 16, 2022

Previous Page

Page 19 of 463

Next Page